5 completed, 1 active not recruiting, 1 terminated. 7 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 5, Active not recruiting 1, Terminated 1 |
Follow SLE: new trials by email Literature Review of SLE trials Research Report on SLE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases COVID-19 vaccine and booster training, and importance - Rheumatic Diseases, COVID-19 Vaccine | Not applicable | Active not recruiting | Northwestern University | 60 | 2024-03-15 | 2026-05-29 |
| Telemedicine for Follow-up of Systemic Lupus Erythematosus Telemedicine, Standard care - SLE | Not applicable | Completed | Chinese University of Hong Kong | 144 | 2020-05-01 | 2022-03-09 |
| Choosing Tests Wisely in Rheumatology Choosing Wisely form - SLE | Not applicable | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 638 | 2018-05-15 | 2022-04-26 |
| Does Balnotherapy Influence the Qualitiy of Life in SLE balneotherapy - SLE | Not applicable | Completed | Polyclinic of the Hospitaller Brothers of St. John of God, Budapest | 30 | 2017-12-01 | 2022-09-29 |
| Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin D "Cholecalciferol" and "C. Xanthorrhiza", "Cholecalciferol" and "placebo" - SLE | Not applicable | Completed | Saiful Anwar Hospital | 39 | 2016-06-10 | 2017-05-17 |
| Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response 0,5 mg Prevenar i.m., 0,5 mg seasonal influenza vaccine i.m. - RA, SLE | Not applicable | Completed | Region Skane | 300 | 2011-10-01 | 2018-10-03 |
| Physical Therapy for Systemic Lupus Erythematosus (SLE) Physical Therapy or Relaxation Therapy - Lupus Erythematosus, Systemic, SLE | Not applicable | Terminated | University of Chicago | 100 | 2003-03-01 | 2013-06-12 |
Lupus Erythematosus, Systemic (2) · COVID-19 (1) · Disease (1) · Rheumatic Diseases (1) · Scleroderma, Diffuse (1) · Syndrome (1) · Vasculitis (1)
Connective Tissue Diseases (4) · Skin and Connective Tissue Diseases (4) · Autoimmune Diseases (2) · Immune System Diseases (2) · Cardiovascular Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Musculoskeletal Diseases (1) · Nidovirales Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumonia (1) · Pneumonia, Viral (1)
Balneology (1) · COVID-19 Vaccines (1) · Cholecalciferol (1) · Physical Therapy Modalities (1) · Relaxation Therapy (1) · Standard of Care (1) · Telemedicine (1)
Chinese University of Hong Kong (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Northwestern University (1) · Polyclinic of the Hospitaller Brothers of St. John of God, Budapest (1) · Region Skane (1) · Saiful Anwar Hospital (1) · University of Chicago (1)
United States (2) · Canada (1) · Hong Kong (1) · Hungary (1) · Sweden (1)
Handono Kalim, Prof. (1) · Jehns Martineus, MD (1) · Meliha C Kapetanovic, MD, PhD (1) · Rosalind Ramsey-Goldman, MD, DrPH (1) · Tammy Utset, MD (1)
PMID 28081972, PMID 28552512, PMID 29325173, PMID 29445400, PMID 30886963, PMID 38458871, PMID 39181556